期刊文献+

用血必净注射液治疗中、重度烧伤患者48例的疗效观察 被引量:1

Clinical Efficacy of Xuebijing Injection in Treatment of 48 Patients with Moderate or Severe Burns
在线阅读 下载PDF
导出
摘要 目的:评价用血必净注射液治疗中、重度烧伤患者的安全性和有效性。方法:将48例中、重度烧伤患者随机分为治疗组和对照组(每组24例);2组均给予常规治疗,而治疗组在常规治疗基础上加用血必净注射液;分析2组患者的体温、心率、血白细胞计数(WBC)、中性粒细胞计数、肝功能指标(AST,ALT)和肾功能指标(BUN,Cr)值的变化,以及抗菌药物的使用情况。结果:与对照组相比,治疗组能显著降低其体温、心率、血白细胞计数和中性粒细胞计数指标值,2组经统计学分析,其差异有统计学意义(P<0.05);肝、肾功能的有关指标值经统计学分析,其差异无统计学意义(P>0.05)。结论:血必净注射液用于治疗中、重度烧伤的疗效确切,且ADR少,临床值得推广应用。 Objective: To evaluate the clinical efficacy of moderate or severe bums using Xuebijing injection. Methods: Forty-eight patients with moderate or servere bums were randomly divided into treatment group (24 cases) and control group (24 cases). The treatment group was treated with routine treatment plus Xuehijing injection, while the control groups was treated with routine treatment. Analysis of patient's body temperature, heart rate, white blood cell count, neutrophil percentage, liver function (AST, ALT), kidney (BUN, Cr), and the use of antimicrobial agents in two groups. Results: Compared with control group, the treatment group can significantly reduce the body temperature, heart rate, WBC and neutrophil percentage parameter values. Through the statistical tests, the difference has statistical signifi- cance. The function of their liver and kidneys HAD no significant difference between the treatment group and control group. Conclusion: The Xuebijing injection for treatment moderate or severe bums has definite effect, less ADRs and worthy of being widely applied in clinical practice.
出处 《抗感染药学》 2014年第1期78-80,共3页 Anti-infection Pharmacy
关键词 烧伤 血必净注射液 合理用药 bums Xuebijing injection rational drag use
  • 相关文献

参考文献8

二级参考文献39

  • 1姚咏明,董胜利,于勇,盛志勇.创伤后肠道细菌/内毒素移位的发病机制与意义[J].世界感染杂志,2004,4(5):433-437. 被引量:7
  • 2梁显泉,李志军,刘红栓,王今达.血必净注射液治疗脓毒症42例[J].中国中西医结合急救杂志,2005,12(4):251-252. 被引量:107
  • 3张会云,曹书华,王今达.活血化瘀法对多脏器功能障碍综合征内毒素血症作用的临床研究[J].中华医院感染学杂志,2005,15(12):1342-1345. 被引量:63
  • 4王文江,姚咏明,咸力明,董宁,孟海东,雪琳,王今达.血必净注射液对烧伤延迟复苏大鼠器官功能及死亡率的影响[J].中国危重病急救医学,2006,18(1):16-18. 被引量:62
  • 5Bone RC, Balk RA, Cerra FB, et al, Definition of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992, 101 (6) : 1644 - 1649.
  • 6Malone DL, Kuhls D, Napolitano LM, et al. Back to basics:validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma, 2001, 51(3) :458 - 463.
  • 7Speilman S, Kemer K, Ahlers O, et al. Early detection of increased tumor necrosis factor alpha ( TNF - α ) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course. Acta Anaesthesiol Scand, 2001,45(3) :362 -365.
  • 8Endo S, Kasai T, Inada K. Evaluation of procalcitonin levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness. Kansenshogaku Zasshi, 1999, 73(3) :195 -198.
  • 9Boermeester MA, Leeuwen PAM, Coyle SM, et al. Interleukin-1 receptor blockade in patients with sepsis syndrome: evidence that interlenkin- 1 contributes to the release of interleukin-6, elastase and phospholipase A2, and to the activation of the complement, coagulation and fibrinolytic systems[J]. Arch Surg, 1995,130(7):739-748.
  • 10Gando S, Kameue T, Nazaki S, et al. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome [ J ]. Thromb Res, 1995,80 (60) : 519- 526.

共引文献78

同被引文献19

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部